APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nicotinamide Mononucleotide (NMN)

Nicotinamide Mononucleotide (NMN) is a molecule naturally found in the body and is a precursor to nicotinamide adenine dinucleotide (NAD+), which plays a crucial role in various cellular processes. NAD+ is involved in energy metabolism, DNA repair, gene expression, and cell signaling.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Nicotinamide Mononucleotide (NMN) is a molecule naturally found in the body and is a precursor to nicotinamide adenine dinucleotide (NAD+), which plays a crucial role in various cellular processes. NAD+ is involved in energy metabolism, DNA repair, gene expression, and cell signaling.

NMN is considered a promising compound in anti-aging research due to its role in boosting NAD+ levels. As humans age, NAD+ levels tend to decline, which may contribute to age-related health issues. By supplementing with NMN, it's hypothesized that NAD+ levels can be replenished, potentially slowing down the aging process and improving overall health.

Selected research

Market Analysis & Forecast

Global Nicotinamide Mononucleotide (NMN) Market Analysis and Forecast 2026-2032

27 December 2025212 pages

Choose your research edition.

Industry ResearchNicotinamide Mononucleotide (NMN) Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Nicotinamide Mononucleotide (NMN) Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Nicotinamide Mononucleotide (NMN) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nicotinamide Mononucleotide (NMN) Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Nicotinamide Mononucleotide (NMN) Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

Nicotinamide Mononucleotide (NMN) is a molecule naturally found in the body and is a precursor to nicotinamide adenine dinucleotide (NAD+), which plays a crucial role in various cellular processes. NAD+ is involved in energy metabolism, DNA repair, gene expression, and cell signaling.

NMN is considered a promising compound in anti-aging research due to its role in boosting NAD+ levels. As humans age, NAD+ levels tend to decline, which may contribute to age-related health issues. By supplementing with NMN, it's hypothesized that NAD+ levels can be replenished, potentially slowing down the aging process and improving overall health.

The global Nicotinamide Mononucleotide (NMN) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Read the full market overview

Nicotinamide Mononucleotide (NMN)'s global sales reached XX (Kg) with a value of US$ XX Million, marking an change of XX% compared to the previous year. This performance has positioned GeneHarbor as the global sales leader, a title it has maintained for several consecutive years. Notably, GeneHarbor's performance in primary markets is also remarkable. In the Chinese market, sales were XX (Kg), a change of XX% from the previous year. In Europe, sales were XX (Kg), showing a year-on-year of XX%. In the US, sales were XX (Kg), a year-on-year change of XX%.

The major global manufacturers in the Nicotinamide Mononucleotide (NMN) market include GeneHarbor, Herbalmax, Genex Formulas, MIRAILAB BIOSCIENCE Inc, Maac10 Formulas, EffePharm, Bontac, CELFULL and Kingdomway, etc. In 2025, the top three vendors accounted for approximately % of the revenue.

In terms of production side, this report researches the Nicotinamide Mononucleotide (NMN) production, growth rate, market share by manufacturers and by region (region level and country level), from 2021 to 2026, and forecast to 2032.

In terms of consumption side, this report focuses on the sales of Nicotinamide Mononucleotide (NMN) by region (region level and country level), by Company, by Type and by Application. from 2021 to 2026 and forecast to 2032.

This report presents an overview of global market for Nicotinamide Mononucleotide (NMN), capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Nicotinamide Mononucleotide (NMN), also provides the consumption of main regions and countries. Of the upcoming market potential for Nicotinamide Mononucleotide (NMN), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Nicotinamide Mononucleotide (NMN) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Nicotinamide Mononucleotide (NMN) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Nicotinamide Mononucleotide (NMN) sales, projected growth trends, production technology, application and end-user industry.

Nicotinamide Mononucleotide (NMN) Segment by Company

GeneHarbor

Herbalmax

Genex Formulas

MIRAILAB BIOSCIENCE Inc

Maac10 Formulas

EffePharm

Bontac

CELFULL

Kingdomway

Oriental Yeast

Blue California (Conagen)

Borealis Pharma B.V. (Longevir®)

Nicotinamide Mononucleotide (NMN) Segment by Type

Content Greater than or Equal to 98%

Content Less than 98%

Nicotinamide Mononucleotide (NMN) Segment by Application

Health Care Products

Cosmetics

Others

Nicotinamide Mononucleotide (NMN) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nicotinamide Mononucleotide (NMN) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nicotinamide Mononucleotide (NMN) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nicotinamide Mononucleotide (NMN).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Nicotinamide Mononucleotide (NMN) production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 4: Sales (consumption), revenue of Nicotinamide Mononucleotide (NMN) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 5: Detailed analysis of Nicotinamide Mononucleotide (NMN) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nicotinamide Mononucleotide (NMN) sales, revenue, price, gross margin, and recent development, etc.

Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 11: China by type, by application, sales, and revenue for each segment.

Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.

Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 15: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Nicotinamide Mononucleotide (NMN) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Content Greater than or Equal to 98% Major Manufacturers Table 3. Content Less than 98% Major Manufacturers Table 4. Global Nicotinamide Mononucleotide (NMN) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Health Care Products Major Manufacturers Table 6. Cosmetics Major Manufacturers Table 7. Others Major Manufacturers Table 8. Nicotinamide Mononucleotide (NMN) Industry Trends Table 9. Nicotinamide Mononucleotide (NMN) Industry Drivers Table 10. Nicotinamide Mononucleotide (NMN) Industry Opportunities and Challenges Table 11. Nicotinamide Mononucleotide (NMN) Industry Restraints Table 12. Global Nicotinamide Mononucleotide (NMN) Production Growth Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Kg) Table 13. Global Nicotinamide Mononucleotide (NMN) Production by Region (2021-2026) & (Kg) Table 14. Global Nicotinamide Mononucleotide (NMN) Production by Region (2027-2032) & (Kg) Table 15. Global Nicotinamide Mononucleotide (NMN) Production Market Share by Region (2021-2026) Table 16. Global Nicotinamide Mononucleotide (NMN) Production Market Share by Region (2027-2032) Table 17. Global Nicotinamide Mononucleotide (NMN) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Nicotinamide Mononucleotide (NMN) Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Nicotinamide Mononucleotide (NMN) Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2021-2026) Table 21. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2027-2032) Table 22. Global Nicotinamide Mononucleotide (NMN) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Kg) Table 23. Global Nicotinamide Mononucleotide (NMN) Sales by Region (2021-2026) & (Kg) Table 24. Global Nicotinamide Mononucleotide (NMN) Sales by Region (2027-2032) & (Kg) Table 25. Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2021-2026) Table 26. Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2027-2032) Table 27. Global Nicotinamide Mononucleotide (NMN) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Nicotinamide Mononucleotide (NMN) Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Manufacturers (2021-2026) Table 31. Global Nicotinamide Mononucleotide (NMN) Sales Price (US$/Kg) of Manufacturers (2021-2026) Table 32. Global Nicotinamide Mononucleotide (NMN) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Nicotinamide Mononucleotide (NMN) Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Nicotinamide Mononucleotide (NMN) Manufacturers, Product Type & Application Table 35. Global Nicotinamide Mononucleotide (NMN) Manufacturers Commercialization Time Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Nicotinamide Mononucleotide (NMN) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 38. Global Nicotinamide Mononucleotide (NMN) Revenue by Type (2021-2026) & (US$ Million) Table 39. Global Nicotinamide Mononucleotide (NMN) Revenue by Type (2027-2032) & (US$ Million) Table 40. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Type (2021-2026) Table 41. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Type (2027-2032) Table 42. Global Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2026) & (Kg) Table 43. Global Nicotinamide Mononucleotide (NMN) Sales by Type (2027-2032) & (Kg) Table 44. Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2021-2026) Table 45. Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2027-2032) Table 46. Global Nicotinamide Mononucleotide (NMN) Price by Type (2021-2026) & (US$/Kg) Table 47. Global Nicotinamide Mononucleotide (NMN) Price by Type (2027-2032) & (US$/Kg) Table 48. Global Nicotinamide Mononucleotide (NMN) Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Nicotinamide Mononucleotide (NMN) Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2021-2026) Table 51. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2027-2032) Table 52. Global Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2026) & (Kg) Table 53. Global Nicotinamide Mononucleotide (NMN) Sales by Application (2027-2032) & (Kg) Table 54. Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2021-2026) Table 55. Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2027-2032) Table 56. Global Nicotinamide Mononucleotide (NMN) Price by Application (2021-2026) & (US$/Kg) Table 57. Global Nicotinamide Mononucleotide (NMN) Price by Application (2027-2032) & (US$/Kg) Table 58. GeneHarbor Company Information Table 59. GeneHarbor Business Overview Table 60. GeneHarbor Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 61. GeneHarbor Nicotinamide Mononucleotide (NMN) Product Portfolio Table 62. GeneHarbor Recent Development Table 63. Herbalmax Company Information Table 64. Herbalmax Business Overview Table 65. Herbalmax Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 66. Herbalmax Nicotinamide Mononucleotide (NMN) Product Portfolio Table 67. Herbalmax Recent Development Table 68. Genex Formulas Company Information Table 69. Genex Formulas Business Overview Table 70. Genex Formulas Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 71. Genex Formulas Nicotinamide Mononucleotide (NMN) Product Portfolio Table 72. Genex Formulas Recent Development Table 73. MIRAILAB BIOSCIENCE Inc Company Information Table 74. MIRAILAB BIOSCIENCE Inc Business Overview Table 75. MIRAILAB BIOSCIENCE Inc Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 76. MIRAILAB BIOSCIENCE Inc Nicotinamide Mononucleotide (NMN) Product Portfolio Table 77. MIRAILAB BIOSCIENCE Inc Recent Development Table 78. Maac10 Formulas Company Information Table 79. Maac10 Formulas Business Overview Table 80. Maac10 Formulas Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 81. Maac10 Formulas Nicotinamide Mononucleotide (NMN) Product Portfolio Table 82. Maac10 Formulas Recent Development Table 83. EffePharm Company Information Table 84. EffePharm Business Overview Table 85. EffePharm Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 86. EffePharm Nicotinamide Mononucleotide (NMN) Product Portfolio Table 87. EffePharm Recent Development Table 88. Bontac Company Information Table 89. Bontac Business Overview Table 90. Bontac Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 91. Bontac Nicotinamide Mononucleotide (NMN) Product Portfolio Table 92. Bontac Recent Development Table 93. CELFULL Company Information Table 94. CELFULL Business Overview Table 95. CELFULL Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 96. CELFULL Nicotinamide Mononucleotide (NMN) Product Portfolio Table 97. CELFULL Recent Development Table 98. Kingdomway Company Information Table 99. Kingdomway Business Overview Table 100. Kingdomway Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 101. Kingdomway Nicotinamide Mononucleotide (NMN) Product Portfolio Table 102. Kingdomway Recent Development Table 103. Oriental Yeast Company Information Table 104. Oriental Yeast Business Overview Table 105. Oriental Yeast Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 106. Oriental Yeast Nicotinamide Mononucleotide (NMN) Product Portfolio Table 107. Oriental Yeast Recent Development Table 108. Blue California (Conagen) Company Information Table 109. Blue California (Conagen) Business Overview Table 110. Blue California (Conagen) Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 111. Blue California (Conagen) Nicotinamide Mononucleotide (NMN) Product Portfolio Table 112. Blue California (Conagen) Recent Development Table 113. Borealis Pharma B.V. (Longevir®) Company Information Table 114. Borealis Pharma B.V. (Longevir®) Business Overview Table 115. Borealis Pharma B.V. (Longevir®) Nicotinamide Mononucleotide (NMN) Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 116. Borealis Pharma B.V. (Longevir®) Nicotinamide Mononucleotide (NMN) Product Portfolio Table 117. Borealis Pharma B.V. (Longevir®) Recent Development Table 118. North America Nicotinamide Mononucleotide (NMN) Revenue by Type (2021-2026) & (US$ Million) Table 119. North America Nicotinamide Mononucleotide (NMN) Revenue by Type (2027-2032) & (US$ Million) Table 120. North America Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2026) & (Kg) Table 121. North America Nicotinamide Mononucleotide (NMN) Sales by Type (2027-2032) & (Kg) Table 122. North America Nicotinamide Mononucleotide (NMN) Sales Price by Type (2021-2026) & (US$/Kg) Table 123. North America Nicotinamide Mononucleotide (NMN) Sales Price by Type (2027-2032) & (US$/Kg) Table 124. North America Nicotinamide Mononucleotide (NMN) Revenue by Application (2021-2026) & (US$ Million) Table 125. North America Nicotinamide Mononucleotide (NMN) Revenue by Application (2027-2032) & (US$ Million) Table 126. North America Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2026) & (Kg) Table 127. North America Nicotinamide Mononucleotide (NMN) Sales by Application (2027-2032) & (Kg) Table 128. North America Nicotinamide Mononucleotide (NMN) Sales Price by Application (2021-2026) & (US$/Kg) Table 129. North America Nicotinamide Mononucleotide (NMN) Sales Price by Application (2027-2032) & (US$/Kg) Table 130. North America Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. North America Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 132. North America Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 133. North America Nicotinamide Mononucleotide (NMN) Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 134. North America Nicotinamide Mononucleotide (NMN) Sales by Country (2021-2026) & (Kg) Table 135. North America Nicotinamide Mononucleotide (NMN) Sales by Country (2027-2032) & (Kg) Table 136. North America Nicotinamide Mononucleotide (NMN) Sales Price by Country (2021-2026) & (US$/Kg) Table 137. North America Nicotinamide Mononucleotide (NMN) Sales Price by Country (2027-2032) & (US$/Kg) Table 138. United States Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 139. Canada Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 140. Mexico Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 141. Europe Nicotinamide Mononucleotide (NMN) Revenue by Type (2021-2026) & (US$ Million) Table 142. Europe Nicotinamide Mononucleotide (NMN) Revenue by Type (2027-2032) & (US$ Million) Table 143. Europe Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2026) & (Kg) Table 144. Europe Nicotinamide Mononucleotide (NMN) Sales by Type (2027-2032) & (Kg) Table 145. Europe Nicotinamide Mononucleotide (NMN) Sales Price by Type (2021-2026) & (US$/Kg) Table 146. Europe Nicotinamide Mononucleotide (NMN) Sales Price by Type (2027-2032) & (US$/Kg) Table 147. Europe Nicotinamide Mononucleotide (NMN) Revenue by Application (2021-2026) & (US$ Million) Table 148. Europe Nicotinamide Mononucleotide (NMN) Revenue by Application (2027-2032) & (US$ Million) Table 149. Europe Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2026) & (Kg) Table 150. Europe Nicotinamide Mononucleotide (NMN) Sales by Application (2027-2032) & (Kg) Table 151. Europe Nicotinamide Mononucleotide (NMN) Sales Price by Application (2021-2026) & (US$/Kg) Table 152. Europe Nicotinamide Mononucleotide (NMN) Sales Price by Application (2027-2032) & (US$/Kg) Table 153. Europe Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. Europe Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 155. Europe Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 156. Europe Nicotinamide Mononucleotide (NMN) Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 157. Europe Nicotinamide Mononucleotide (NMN) Sales by Country (2021-2026) & (Kg) Table 158. Europe Nicotinamide Mononucleotide (NMN) Sales by Country (2027-2032) & (Kg) Table 159. Europe Nicotinamide Mononucleotide (NMN) Sales Price by Country (2021-2026) & (US$/Kg) Table 160. Europe Nicotinamide Mononucleotide (NMN) Sales Price by Country (2027-2032) & (US$/Kg) Table 161. Germany Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 162. France Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 163. U.K. Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 164. Italy Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 165. Russia Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 166. Spain Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 167. Netherlands Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 168. Switzerland Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 169. Sweden Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 170. Poland Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 171. China Nicotinamide Mononucleotide (NMN) Revenue by Type (2021-2026) & (US$ Million) Table 172. China Nicotinamide Mononucleotide (NMN) Revenue by Type (2027-2032) & (US$ Million) Table 173. China Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2026) & (Kg) Table 174. China Nicotinamide Mononucleotide (NMN) Sales by Type (2027-2032) & (Kg) Table 175. China Nicotinamide Mononucleotide (NMN) Sales Price by Type (2021-2026) & (US$/Kg) Table 176. China Nicotinamide Mononucleotide (NMN) Sales Price by Type (2027-2032) & (US$/Kg) Table 177. China Nicotinamide Mononucleotide (NMN) Revenue by Application (2021-2026) & (US$ Million) Table 178. China Nicotinamide Mononucleotide (NMN) Revenue by Application (2027-2032) & (US$ Million) Table 179. China Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2026) & (Kg) Table 180. China Nicotinamide Mononucleotide (NMN) Sales by Application (2027-2032) & (Kg) Table 181. China Nicotinamide Mononucleotide (NMN) Sales Price by Application (2021-2026) & (US$/Kg) Table 182. China Nicotinamide Mononucleotide (NMN) Sales Price by Application (2027-2032) & (US$/Kg) Table 183. Asia Nicotinamide Mononucleotide (NMN) Revenue by Type (2021-2026) & (US$ Million) Table 184. Asia Nicotinamide Mononucleotide (NMN) Revenue by Type (2027-2032) & (US$ Million) Table 185. Asia Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2026) & (Kg) Table 186. Asia Nicotinamide Mononucleotide (NMN) Sales by Type (2027-2032) & (Kg) Table 187. Asia Nicotinamide Mononucleotide (NMN) Sales Price by Type (2021-2026) & (US$/Kg) Table 188. Asia Nicotinamide Mononucleotide (NMN) Sales Price by Type (2027-2032) & (US$/Kg) Table 189. Asia Nicotinamide Mononucleotide (NMN) Revenue by Application (2021-2026) & (US$ Million) Table 190. Asia Nicotinamide Mononucleotide (NMN) Revenue by Application (2027-2032) & (US$ Million) Table 191. Asia Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2026) & (Kg) Table 192. Asia Nicotinamide Mononucleotide (NMN) Sales by Application (2027-2032) & (Kg) Table 193. Asia Nicotinamide Mononucleotide (NMN) Sales Price by Application (2021-2026) & (US$/Kg) Table 194. Asia Nicotinamide Mononucleotide (NMN) Sales Price by Application (2027-2032) & (US$/Kg) Table 195. Asia Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 196. Asia Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 197. Asia Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 198. Asia Nicotinamide Mononucleotide (NMN) Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 199. Asia Nicotinamide Mononucleotide (NMN) Sales by Country (2021-2026) & (Kg) Table 200. Asia Nicotinamide Mononucleotide (NMN) Sales by Country (2027-2032) & (Kg) Table 201. Asia Nicotinamide Mononucleotide (NMN) Sales Price by Country (2021-2026) & (US$/Kg) Table 202. Asia Nicotinamide Mononucleotide (NMN) Sales Price by Country (2027-2032) & (US$/Kg) Table 203. Japan Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 204. South Korea Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 205. India Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 206. Australia Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 207. Taiwan Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 208. Southeast Asia Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 209. SAMEA Nicotinamide Mononucleotide (NMN) Revenue by Type (2021-2026) & (US$ Million) Table 210. SAMEA Nicotinamide Mononucleotide (NMN) Revenue by Type (2027-2032) & (US$ Million) Table 211. SAMEA Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2026) & (Kg) Table 212. SAMEA Nicotinamide Mononucleotide (NMN) Sales by Type (2027-2032) & (Kg) Table 213. SAMEA Nicotinamide Mononucleotide (NMN) Sales Price by Type (2021-2026) & (US$/Kg) Table 214. SAMEA Nicotinamide Mononucleotide (NMN) Sales Price by Type (2027-2032) & (US$/Kg) Table 215. SAMEA Nicotinamide Mononucleotide (NMN) Revenue by Application (2021-2026) & (US$ Million) Table 216. SAMEA Nicotinamide Mononucleotide (NMN) Revenue by Application (2027-2032) & (US$ Million) Table 217. SAMEA Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2026) & (Kg) Table 218. SAMEA Nicotinamide Mononucleotide (NMN) Sales by Application (2027-2032) & (Kg) Table 219. SAMEA Nicotinamide Mononucleotide (NMN) Sales Price by Application (2021-2026) & (US$/Kg) Table 220. SAMEA Nicotinamide Mononucleotide (NMN) Sales Price by Application (2027-2032) & (US$/Kg) Table 221. SAMEA Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 222. SAMEA Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 223. SAMEA Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 224. SAMEA Nicotinamide Mononucleotide (NMN) Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 225. SAMEA Nicotinamide Mononucleotide (NMN) Sales by Country (2021-2026) & (Kg) Table 226. SAMEA Nicotinamide Mononucleotide (NMN) Sales by Country (2027-2032) & (Kg) Table 227. SAMEA Nicotinamide Mononucleotide (NMN) Sales Price by Country (2021-2026) & (US$/Kg) Table 228. SAMEA Nicotinamide Mononucleotide (NMN) Sales Price by Country (2027-2032) & (US$/Kg) Table 229. Brazil Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 230. Argentina Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 231. Chile Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 232. Colombia Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 233. Peru Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 234. Saudi Arabia Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 235. Israel Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 236. UAE Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 237. Turkey Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 238. Iran Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 239. Egypt Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Table 240. Key Raw Materials Table 241. Raw Materials Key Suppliers Table 242. Nicotinamide Mononucleotide (NMN) Distributors List Table 243. Nicotinamide Mononucleotide (NMN) Customers List Table 244. Research Programs/Design for This Report Table 245. Authors List of This Report Table 246. Secondary Sources Table 247. Primary Sources List of Figures Figure 1. Nicotinamide Mononucleotide (NMN) Product Image Figure 2. Global Nicotinamide Mononucleotide (NMN) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nicotinamide Mononucleotide (NMN) Market Size Share 2021 VS 2025 VS 2032 Figure . Content Greater than or Equal to 98% Image Figure 1. Content Less than 98% Image Figure 2. Global Nicotinamide Mononucleotide (NMN) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nicotinamide Mononucleotide (NMN) Market Size Share 2021 VS 2025 VS 2032 Figure 4. Health Care Products Image Figure 5. Cosmetics Image Figure 6. Others Image Figure 7. Global Nicotinamide Mononucleotide (NMN) Capacity, Capacity Utilization (2021-2032) & (Kg) Figure 8. Global Nicotinamide Mononucleotide (NMN) Production by Region: 2021 VS 2025 VS 2032 (Kg) Figure 9. Global Nicotinamide Mononucleotide (NMN) Production Market Share by Region: 2025 Versus 2032 Figure 10. Global Nicotinamide Mononucleotide (NMN) Production Market Share by Region (2021-2032) Figure 11. North America Nicotinamide Mononucleotide (NMN) Production Growth Rate (2021-2032) & (Kg) Figure 12. Europe Nicotinamide Mononucleotide (NMN) Production Growth Rate (2021-2032) & (Kg) Figure 13. China Nicotinamide Mononucleotide (NMN) Production Growth Rate (2021-2032) & (Kg) Figure 14. Japan Nicotinamide Mononucleotide (NMN) Production Growth Rate (2021-2032) & (Kg) Figure 15. Global Nicotinamide Mononucleotide (NMN) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Nicotinamide Mononucleotide (NMN) Revenue (2021-2032) & (US$ Million) Figure 17. Global Nicotinamide Mononucleotide (NMN) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region: 2025 Versus 2032 Figure 19. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2021-2032) Figure 20. Global Nicotinamide Mononucleotide (NMN) Sales (2021-2032) & (Kg) Figure 21. Global Nicotinamide Mononucleotide (NMN) Sales by Region: 2021 VS 2025 VS 2032 (Kg) Figure 22. Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2021-2032) Figure 23. North America Nicotinamide Mononucleotide (NMN) Sales YoY (2021-2032) & (Kg) Figure 24. Europe Nicotinamide Mononucleotide (NMN) Sales YoY (2021-2032) & (Kg) Figure 25. China Nicotinamide Mononucleotide (NMN) Sales YoY (2021-2032) & (Kg) Figure 26. Asia (Excluding China) Nicotinamide Mononucleotide (NMN) Sales YoY (2021-2032) & (Kg) Figure 27. South America, Middle East and Africa Nicotinamide Mononucleotide (NMN) Sales YoY (2021-2032) & (Kg) Figure 28. Global Nicotinamide Mononucleotide (NMN) Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 29. Global Nicotinamide Mononucleotide (NMN) Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Type (2021-2032) Figure 32. Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2021-2032) Figure 33. Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2021-2032) Figure 34. Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2021-2032) Figure 35. North America Nicotinamide Mononucleotide (NMN) Revenue Share by Type (2021-2032) Figure 36. North America Nicotinamide Mononucleotide (NMN) Sales Share by Type (2021-2032) Figure 37. North America Nicotinamide Mononucleotide (NMN) Revenue Share by Application (2021-2032) Figure 38. North America Nicotinamide Mononucleotide (NMN) Sales Share by Application (2021-2032) Figure 39. North America Nicotinamide Mononucleotide (NMN) Revenue Share by Country (2021-2032) Figure 40. North America Nicotinamide Mononucleotide (NMN) Sales Share by Country (2021-2032) Figure 41. Europe Nicotinamide Mononucleotide (NMN) Revenue Share by Type (2021-2032) Figure 42. Europe Nicotinamide Mononucleotide (NMN) Sales Share by Type (2021-2032) Figure 43. Europe Nicotinamide Mononucleotide (NMN) Revenue Share by Application (2021-2032) Figure 44. Europe Nicotinamide Mononucleotide (NMN) Sales Share by Application (2021-2032) Figure 45. Europe Nicotinamide Mononucleotide (NMN) Revenue Share by Country (2021-2032) Figure 46. Europe Nicotinamide Mononucleotide (NMN) Sales Share by Country (2021-2032) Figure 47. China Nicotinamide Mononucleotide (NMN) Revenue Share by Type (2021-2032) Figure 48. China Nicotinamide Mononucleotide (NMN) Sales Share by Type (2021-2032) Figure 49. China Nicotinamide Mononucleotide (NMN) Revenue Share by Application (2021-2032) Figure 50. China Nicotinamide Mononucleotide (NMN) Sales Share by Application (2021-2032) Figure 51. Asia Nicotinamide Mononucleotide (NMN) Revenue Share by Type (2021-2032) Figure 52. Asia Nicotinamide Mononucleotide (NMN) Sales Share by Type (2021-2032) Figure 53. Asia Nicotinamide Mononucleotide (NMN) Revenue Share by Application (2021-2032) Figure 54. Asia Nicotinamide Mononucleotide (NMN) Sales Share by Application (2021-2032) Figure 55. Asia Nicotinamide Mononucleotide (NMN) Revenue Share by Country (2021-2032) Figure 56. Asia Nicotinamide Mononucleotide (NMN) Sales Share by Country (2021-2032) Figure 57. SAMEA Nicotinamide Mononucleotide (NMN) Revenue Share by Type (2021-2032) Figure 58. SAMEA Nicotinamide Mononucleotide (NMN) Sales Share by Type (2021-2032) Figure 59. SAMEA Nicotinamide Mononucleotide (NMN) Revenue Share by Application (2021-2032) Figure 60. SAMEA Nicotinamide Mononucleotide (NMN) Sales Share by Application (2021-2032) Figure 61. SAMEA Nicotinamide Mononucleotide (NMN) Revenue Share by Country (2021-2032) Figure 62. SAMEA Nicotinamide Mononucleotide (NMN) Sales Share by Country (2021-2032) Figure 63. Nicotinamide Mononucleotide (NMN) Value Chain Figure 64. Manufacturing Cost Structure Figure 65. Nicotinamide Mononucleotide (NMN) Production Mode & Process Figure 66. Direct Comparison with Distribution Share Figure 67. Distributors Profiles Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Content Greater than or Equal to 98%
  • Content Less than 98%
Applications
  • Health Care Products
  • Cosmetics
  • Others
Companies covered
  • GeneHarbor
  • Herbalmax
  • Genex Formulas
  • MIRAILAB BIOSCIENCE Inc
  • Maac10 Formulas
  • EffePharm
  • Bontac
  • CELFULL
  • Kingdomway
  • Oriental Yeast
  • Blue California (Conagen)
  • Borealis Pharma B.V. (Longevir®)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Nicotinamide Mononucleotide (NMN) Market by Type
  3. 1.2.1 Global Nicotinamide Mononucleotide (NMN) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Content Greater than or Equal to 98%
  5. 1.2.3 Content Less than 98%
  6. 1.3 Nicotinamide Mononucleotide (NMN) Market by Application
  7. 1.3.1 Global Nicotinamide Mononucleotide (NMN) Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Health Care Products
  9. 1.3.3 Cosmetics
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Nicotinamide Mononucleotide (NMN) Market Dynamics
  1. 2.1 Nicotinamide Mononucleotide (NMN) Industry Trends
  2. 2.2 Nicotinamide Mononucleotide (NMN) Industry Drivers
  3. 2.3 Nicotinamide Mononucleotide (NMN) Industry Opportunities and Challenges
  4. 2.4 Nicotinamide Mononucleotide (NMN) Industry Restraints
3 Global Nicotinamide Mononucleotide (NMN) Production Overview
  1. 3.1 Global Nicotinamide Mononucleotide (NMN) Production Capacity (2021-2032)
  2. 3.2 Global Nicotinamide Mononucleotide (NMN) Production by Region: 2021 VS 2025 VS 2032
  3. 3.3 Global Nicotinamide Mononucleotide (NMN) Production by Region
  4. 3.3.1 Global Nicotinamide Mononucleotide (NMN) Production by Region (2021-2026)
  5. 3.3.2 Global Nicotinamide Mononucleotide (NMN) Production by Region (2027-2032)
  6. 3.3.3 Global Nicotinamide Mononucleotide (NMN) Production Market Share by Region (2021-2032)
  7. 3.4 North America
  8. 3.5 Europe
  9. 3.6 China
  10. 3.7 Japan
4 Global Market Growth Prospects
  1. 4.1 Global Nicotinamide Mononucleotide (NMN) Revenue Estimates and Forecasts (2021-2032)
  2. 4.2 Global Nicotinamide Mononucleotide (NMN) Revenue by Region
  3. 4.2.1 Global Nicotinamide Mononucleotide (NMN) Revenue by Region: 2021 VS 2025 VS 2032
  4. 4.2.2 Global Nicotinamide Mononucleotide (NMN) Revenue by Region (2021-2026)
  5. 4.2.3 Global Nicotinamide Mononucleotide (NMN) Revenue by Region (2027-2032)
  6. 4.2.4 Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2021-2032)
  7. 4.3 Global Nicotinamide Mononucleotide (NMN) Sales Estimates and Forecasts 2021-2032
  8. 4.4 Global Nicotinamide Mononucleotide (NMN) Sales by Region
  9. 4.4.1 Global Nicotinamide Mononucleotide (NMN) Sales by Region: 2021 VS 2025 VS 2032
  10. 4.4.2 Global Nicotinamide Mononucleotide (NMN) Sales by Region (2021-2026)
  11. 4.4.3 Global Nicotinamide Mononucleotide (NMN) Sales by Region (2027-2032)
  12. 4.4.4 Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2021-2032)
  13. 4.5 North America
  14. 4.6 Europe
  15. 4.7 China
  16. 4.8 Asia (Excluding China)
  17. 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
  1. 5.1 Global Nicotinamide Mononucleotide (NMN) Revenue by Manufacturers
  2. 5.1.1 Global Nicotinamide Mononucleotide (NMN) Revenue by Manufacturers (2021-2026)
  3. 5.1.2 Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Manufacturers (2021-2026)
  4. 5.1.3 Global Nicotinamide Mononucleotide (NMN) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 5.2 Global Nicotinamide Mononucleotide (NMN) Sales by Manufacturers
  6. 5.2.1 Global Nicotinamide Mononucleotide (NMN) Sales by Manufacturers (2021-2026)
  7. 5.2.2 Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Manufacturers (2021-2026)
  8. 5.2.3 Global Nicotinamide Mononucleotide (NMN) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 5.3 Global Nicotinamide Mononucleotide (NMN) Sales Price by Manufacturers (2021-2026)
  10. 5.4 Global Nicotinamide Mononucleotide (NMN) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 5.5 Global Nicotinamide Mononucleotide (NMN) Key Manufacturers Manufacturing Sites & Headquarters
  12. 5.6 Global Nicotinamide Mononucleotide (NMN) Manufacturers, Product Type & Application
  13. 5.7 Global Nicotinamide Mononucleotide (NMN) Manufacturers Commercialization Time
  14. 5.8 Market Competitive Analysis
  15. 5.8.1 Global Nicotinamide Mononucleotide (NMN) Market CR5 and HHI
  16. 5.8.2 2025 Nicotinamide Mononucleotide (NMN) Tier 1, Tier 2, and Tier 3
6 Nicotinamide Mononucleotide (NMN) Market by Type
  1. 6.1 Global Nicotinamide Mononucleotide (NMN) Revenue by Type
  2. 6.1.1 Global Nicotinamide Mononucleotide (NMN) Revenue by Type (2021-2032) & (US$ Million)
  3. 6.1.2 Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Type (2021-2032)
  4. 6.2 Global Nicotinamide Mononucleotide (NMN) Sales by Type
  5. 6.2.1 Global Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2032) & (Kg)
  6. 6.2.2 Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2021-2032)
  7. 6.3 Global Nicotinamide Mononucleotide (NMN) Price by Type
7 Nicotinamide Mononucleotide (NMN) Market by Application
  1. 7.1 Global Nicotinamide Mononucleotide (NMN) Revenue by Application
  2. 7.1.1 Global Nicotinamide Mononucleotide (NMN) Revenue by Application (2021-2032) & (US$ Million)
  3. 7.1.2 Global Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2021-2032)
  4. 7.2 Global Nicotinamide Mononucleotide (NMN) Sales by Application
  5. 7.2.1 Global Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2032) & (Kg)
  6. 7.2.2 Global Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2021-2032)
  7. 7.3 Global Nicotinamide Mononucleotide (NMN) Price by Application
8 Company Profiles
  1. 8.1 GeneHarbor
  2. 8.1.1 GeneHarbor Company Information
  3. 8.1.2 GeneHarbor Business Overview
  4. 8.1.3 GeneHarbor Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 8.1.4 GeneHarbor Nicotinamide Mononucleotide (NMN) Product Portfolio
  6. 8.1.5 GeneHarbor Recent Developments
  7. 8.2 Herbalmax
  8. 8.2.1 Herbalmax Company Information
  9. 8.2.2 Herbalmax Business Overview
  10. 8.2.3 Herbalmax Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 8.2.4 Herbalmax Nicotinamide Mononucleotide (NMN) Product Portfolio
  12. 8.2.5 Herbalmax Recent Developments
  13. 8.3 Genex Formulas
  14. 8.3.1 Genex Formulas Company Information
  15. 8.3.2 Genex Formulas Business Overview
  16. 8.3.3 Genex Formulas Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 8.3.4 Genex Formulas Nicotinamide Mononucleotide (NMN) Product Portfolio
  18. 8.3.5 Genex Formulas Recent Developments
  19. 8.4 MIRAILAB BIOSCIENCE Inc
  20. 8.4.1 MIRAILAB BIOSCIENCE Inc Company Information
  21. 8.4.2 MIRAILAB BIOSCIENCE Inc Business Overview
  22. 8.4.3 MIRAILAB BIOSCIENCE Inc Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 8.4.4 MIRAILAB BIOSCIENCE Inc Nicotinamide Mononucleotide (NMN) Product Portfolio
  24. 8.4.5 MIRAILAB BIOSCIENCE Inc Recent Developments
  25. 8.5 Maac10 Formulas
  26. 8.5.1 Maac10 Formulas Company Information
  27. 8.5.2 Maac10 Formulas Business Overview
  28. 8.5.3 Maac10 Formulas Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 8.5.4 Maac10 Formulas Nicotinamide Mononucleotide (NMN) Product Portfolio
  30. 8.5.5 Maac10 Formulas Recent Developments
  31. 8.6 EffePharm
  32. 8.6.1 EffePharm Company Information
  33. 8.6.2 EffePharm Business Overview
  34. 8.6.3 EffePharm Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 8.6.4 EffePharm Nicotinamide Mononucleotide (NMN) Product Portfolio
  36. 8.6.5 EffePharm Recent Developments
  37. 8.7 Bontac
  38. 8.7.1 Bontac Company Information
  39. 8.7.2 Bontac Business Overview
  40. 8.7.3 Bontac Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 8.7.4 Bontac Nicotinamide Mononucleotide (NMN) Product Portfolio
  42. 8.7.5 Bontac Recent Developments
  43. 8.8 CELFULL
  44. 8.8.1 CELFULL Company Information
  45. 8.8.2 CELFULL Business Overview
  46. 8.8.3 CELFULL Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 8.8.4 CELFULL Nicotinamide Mononucleotide (NMN) Product Portfolio
  48. 8.8.5 CELFULL Recent Developments
  49. 8.9 Kingdomway
  50. 8.9.1 Kingdomway Company Information
  51. 8.9.2 Kingdomway Business Overview
  52. 8.9.3 Kingdomway Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 8.9.4 Kingdomway Nicotinamide Mononucleotide (NMN) Product Portfolio
  54. 8.9.5 Kingdomway Recent Developments
  55. 8.10 Oriental Yeast
  56. 8.10.1 Oriental Yeast Company Information
  57. 8.10.2 Oriental Yeast Business Overview
  58. 8.10.3 Oriental Yeast Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 8.10.4 Oriental Yeast Nicotinamide Mononucleotide (NMN) Product Portfolio
  60. 8.10.5 Oriental Yeast Recent Developments
  61. 8.11 Blue California (Conagen)
  62. 8.11.1 Blue California (Conagen) Company Information
  63. 8.11.2 Blue California (Conagen) Business Overview
  64. 8.11.3 Blue California (Conagen) Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 8.11.4 Blue California (Conagen) Nicotinamide Mononucleotide (NMN) Product Portfolio
  66. 8.11.5 Blue California (Conagen) Recent Developments
  67. 8.12 Borealis Pharma B.V. (Longevir®)
  68. 8.12.1 Borealis Pharma B.V. (Longevir®) Company Information
  69. 8.12.2 Borealis Pharma B.V. (Longevir®) Business Overview
  70. 8.12.3 Borealis Pharma B.V. (Longevir®) Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 8.12.4 Borealis Pharma B.V. (Longevir®) Nicotinamide Mononucleotide (NMN) Product Portfolio
  72. 8.12.5 Borealis Pharma B.V. (Longevir®) Recent Developments
9 North America
  1. 9.1 North America Nicotinamide Mononucleotide (NMN) Market Size by Type
  2. 9.1.1 North America Nicotinamide Mononucleotide (NMN) Revenue by Type (2021-2032)
  3. 9.1.2 North America Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2032)
  4. 9.1.3 North America Nicotinamide Mononucleotide (NMN) Price by Type (2021-2032)
  5. 9.2 North America Nicotinamide Mononucleotide (NMN) Market Size by Application
  6. 9.2.1 North America Nicotinamide Mononucleotide (NMN) Revenue by Application (2021-2032)
  7. 9.2.2 North America Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2032)
  8. 9.2.3 North America Nicotinamide Mononucleotide (NMN) Price by Application (2021-2032)
  9. 9.3 North America Nicotinamide Mononucleotide (NMN) Market Size by Country
  10. 9.3.1 North America Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 North America Nicotinamide Mononucleotide (NMN) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 North America Nicotinamide Mononucleotide (NMN) Price by Country (2021-2032)
  13. 9.3.4 United States
  14. 9.3.5 Canada
  15. 9.3.6 Mexico
10 Europe
  1. 10.1 Europe Nicotinamide Mononucleotide (NMN) Market Size by Type
  2. 10.1.1 Europe Nicotinamide Mononucleotide (NMN) Revenue by Type (2021-2032)
  3. 10.1.2 Europe Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2032)
  4. 10.1.3 Europe Nicotinamide Mononucleotide (NMN) Price by Type (2021-2032)
  5. 10.2 Europe Nicotinamide Mononucleotide (NMN) Market Size by Application
  6. 10.2.1 Europe Nicotinamide Mononucleotide (NMN) Revenue by Application (2021-2032)
  7. 10.2.2 Europe Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2032)
  8. 10.2.3 Europe Nicotinamide Mononucleotide (NMN) Price by Application (2021-2032)
  9. 10.3 Europe Nicotinamide Mononucleotide (NMN) Market Size by Country
  10. 10.3.1 Europe Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 10.3.2 Europe Nicotinamide Mononucleotide (NMN) Sales by Country (2021 VS 2025 VS 2032)
  12. 10.3.3 Europe Nicotinamide Mononucleotide (NMN) Price by Country (2021-2032)
  13. 10.3.4 Germany
  14. 10.3.5 France
  15. 10.3.6 U.K.
  16. 10.3.7 Italy
  17. 10.3.8 Russia
  18. 10.3.9 Spain
  19. 10.3.10 Netherlands
  20. 10.3.11 Switzerland
  21. 10.3.12 Sweden
11 China
  1. 11.1 China Nicotinamide Mononucleotide (NMN) Market Size by Type
  2. 11.1.1 China Nicotinamide Mononucleotide (NMN) Revenue by Type (2021-2032)
  3. 11.1.2 China Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2032)
  4. 11.1.3 China Nicotinamide Mononucleotide (NMN) Price by Type (2021-2032)
  5. 11.2 China Nicotinamide Mononucleotide (NMN) Market Size by Application
  6. 11.2.1 China Nicotinamide Mononucleotide (NMN) Revenue by Application (2021-2032)
  7. 11.2.2 China Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2032)
  8. 11.2.3 China Nicotinamide Mononucleotide (NMN) Price by Application (2021-2032)
12 Asia (Excluding China)
  1. 12.1 Asia Nicotinamide Mononucleotide (NMN) Market Size by Type
  2. 12.1.1 Asia Nicotinamide Mononucleotide (NMN) Revenue by Type (2021-2032)
  3. 12.1.2 Asia Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2032)
  4. 12.1.3 Asia Nicotinamide Mononucleotide (NMN) Price by Type (2021-2032)
  5. 12.2 Asia Nicotinamide Mononucleotide (NMN) Market Size by Application
  6. 12.2.1 Asia Nicotinamide Mononucleotide (NMN) Revenue by Application (2021-2032)
  7. 12.2.2 Asia Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2032)
  8. 12.2.3 Asia Nicotinamide Mononucleotide (NMN) Price by Application (2021-2032)
  9. 12.3 Asia Nicotinamide Mononucleotide (NMN) Market Size by Country
  10. 12.3.1 Asia Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 Asia Nicotinamide Mononucleotide (NMN) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 Asia Nicotinamide Mononucleotide (NMN) Price by Country (2021-2032)
  13. 12.3.4 Japan
  14. 12.3.5 South Korea
  15. 12.3.6 India
  16. 12.3.7 Australia
  17. 12.3.8 Taiwan
  18. 12.3.9 Southeast Asia
13 South America, Middle East and Africa
  1. 13.1 SAMEA Nicotinamide Mononucleotide (NMN) Market Size by Type
  2. 13.1.1 SAMEA Nicotinamide Mononucleotide (NMN) Revenue by Type (2021-2032)
  3. 13.1.2 SAMEA Nicotinamide Mononucleotide (NMN) Sales by Type (2021-2032)
  4. 13.1.3 SAMEA Nicotinamide Mononucleotide (NMN) Price by Type (2021-2032)
  5. 13.2 SAMEA Nicotinamide Mononucleotide (NMN) Market Size by Application
  6. 13.2.1 SAMEA Nicotinamide Mononucleotide (NMN) Revenue by Application (2021-2032)
  7. 13.2.2 SAMEA Nicotinamide Mononucleotide (NMN) Sales by Application (2021-2032)
  8. 13.2.3 SAMEA Nicotinamide Mononucleotide (NMN) Price by Application (2021-2032)
  9. 13.3 SAMEA Nicotinamide Mononucleotide (NMN) Market Size by Country
  10. 13.3.1 SAMEA Nicotinamide Mononucleotide (NMN) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 13.3.2 SAMEA Nicotinamide Mononucleotide (NMN) Sales by Country (2021 VS 2025 VS 2032)
  12. 13.3.3 SAMEA Nicotinamide Mononucleotide (NMN) Price by Country (2021-2032)
  13. 13.3.4 Brazil
  14. 13.3.5 Argentina
  15. 13.3.6 Chile
  16. 13.3.7 Colombia
  17. 13.3.8 Peru
  18. 13.3.9 Saudi Arabia
  19. 13.3.10 Israel
  20. 13.3.11 UAE
  21. 13.3.12 Turkey
  22. 13.3.13 Iran
  23. 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
  1. 14.1 Nicotinamide Mononucleotide (NMN) Value Chain Analysis
  2. 14.1.1 Nicotinamide Mononucleotide (NMN) Key Raw Materials
  3. 14.1.2 Raw Materials Key Suppliers
  4. 14.1.3 Manufacturing Cost Structure
  5. 14.1.4 Nicotinamide Mononucleotide (NMN) Production Mode & Process
  6. 14.2 Nicotinamide Mononucleotide (NMN) Sales Channels Analysis
  7. 14.2.1 Direct Comparison with Distribution Share
  8. 14.2.2 Nicotinamide Mononucleotide (NMN) Distributors
  9. 14.2.3 Nicotinamide Mononucleotide (NMN) Customers
15 Concluding Insights
    16 Appendix
    1. 16.1 Reasons for Doing This Study
    2. 16.2 Research Methodology
    3. 16.3 Research Process
    4. 16.4 Authors List of This Report
    5. 16.5 Data Source
    6. 16.5.1 Secondary Sources
    7. 16.5.2 Primary Sources
    8. 16.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst